Health Care · In Vitro & In Vivo Diagnostic Substances · Nasdaq · CIK 949858 · FYE Dec 31 · Prices AT CLOSE 2026-08-20 (USD) Last $8.02 · Day −5.98% · Mkt cap $878M · 1Y +210.9% · Off 52W high −6.9% · Vol (1Y) 92.0% Price2023-08-21 → 2026-08-20 ACHV close: $4.88 on 2023-08-21 to $8.02 on 2026-08-20. Split-adj closes · 240 of 5,294 · price returnⓘ At a glance | Short interest15.8% of sh out | | Days to cover15.0d | | 13F net flow (QoQ)−1.31% | | Top-10 13F concentration75.7% | | Next report (est.)2026-11-10 |
SI 2026-07-31 · 13F 2026-Q1ⓘ Key fundamentalsFY 2025 | Earnings (TTM)-$114.0M | | ROE−257.7% |
FY ratios · TTM sales/earnings (USD)ⓘ Trailing returns | YTD+61.4% | | 1Y+210.9% | | 3Y+64.3% | | 5Y+16.1% | | 10Y−99.4% | | Since incept. (ann.)−37.0% |
Total return · from 2005-07-11ⓘ Risk | Ann. volatility (1Y)92.0% | | Ann. volatility (3Y)79.8% | | Sharpe (1Y)1.69 | | Sharpe (3Y)0.62 | | Max drawdown (1Y)−54.5% | | Max drawdown (3Y)−66.2% | | Beta (3Y vs SPY)2.73 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 | Manager | Shares | Value | % sh out | QoQ |
|---|
| FRANKLIN RESOURCES INC | 4.4M | $13M | 8.21% | +0.0% | | Propel Bio Management, LLC | 3.8M | $11M | 7.11% | +0.0% | | VANGUARD CAPITAL MANAGEMENT LLC | 2.2M | $6M | 4.14% | new | | Simplify Asset Management Inc. | 1.2M | $3M | 2.22% | +0.0% | | MILLENNIUM MANAGEMENT LLC | 1.1M | $3M | 2.02% | −20.7% | | MARSHALL WACE, LLP | 1.0M | $3M | 1.91% | +0.0% | | LPL Financial LLC | 728,448 | $2M | 1.37% | +15.1% | | Nantahala Capital Management, LLC | 648,885 | $2M | 1.22% | +0.0% |
Δ vs 2025-Q4ⓘ Latest reported quarterslast report 2026-08-11 | Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|
| 2026-06-30 | 2026-08-11 | −$0.80 | — | — | — | | 2026-03-31 | 2026-05-12 | −$0.19 | — | — | — | | 2025-09-30 | 2025-11-06 | −$0.28 | — | — | — | | 2025-06-30 | 2025-08-07 | −$0.37 | — | — | — |
As-reported XBRL · next 2026-11-10 est.ⓘ Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
|
